HUMACYTE INC (HUMA)

US44486Q1031 - Common Stock

4.65  +0.01 (+0.22%)

After market: 4.6 -0.05 (-1.08%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to HUMA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 13.26. This target is 185.16% above the current price.
HUMA was analyzed by 13 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about HUMA.
In the previous month the buy percentage consensus was at a similar level.
HUMA was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 4.656.0612.2413.2626.25 - 30.32% 163.23% 185.16% 464.52%
Up and Down Grades
Date Firm Action Rating
2024-12-23 Benchmark Maintains Buy -> Buy
2024-12-20 D. Boral Capital Maintains Buy -> Buy
2024-12-20 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-21 D. Boral Capital Maintains Buy -> Buy
2024-11-18 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-11 D. Boral Capital Maintains Buy -> Buy
2024-11-05 HC Wainwright & Co. Maintains Buy -> Buy
2024-10-28 EF Hutton Maintains Buy -> Buy
2024-10-18 TD Cowen Reiterate Buy -> Buy
2024-10-18 BTIG Reiterate Buy -> Buy
2024-10-10 Benchmark Reiterate Buy -> Buy
2024-10-01 EF Hutton Maintains Buy -> Buy
2024-09-20 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-09 EF Hutton Initiate Buy
2024-09-05 Benchmark Reiterate Buy -> Buy
2024-08-14 Benchmark Reiterate Buy -> Buy
2024-08-12 Benchmark Reiterate Buy -> Buy
2024-07-15 BTIG Maintains Buy -> Buy
2024-07-02 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-07-02 Benchmark Reiterate Buy -> Buy
2024-05-24 Benchmark Reiterate Buy -> Buy
2024-05-13 Benchmark Reiterate Buy -> Buy
2024-04-01 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-03-26 Piper Sandler Maintains Neutral -> Neutral
2024-03-25 Benchmark Reiterate Buy -> Buy
2024-03-08 Piper Sandler Maintains Neutral -> Neutral
2023-12-27 Benchmark Maintains Buy -> Buy
2023-12-11 HC Wainwright & Co. Initiate Buy
2023-11-10 Piper Sandler Maintains Neutral -> Neutral